Dislipidemias e aterosclerose: Guia prático de casos clínicos

Faludi, AA; Bertolami, MC.
São Paulo; Atha Comunicação; 2012. 134 p. il..
Português | DANTEPAZZANESE, SES SP - Acervo Instituto Dante Pazzanese de Cardiologia | ID: dan-3963

Documentos relacionados

  1. Genome Editing in Dyslipidemia and Atherosclerosis.
  2. [Non-pharmaceutical treatment of dyslipidemia: review of current methods of diet and nutraceuticals].
  3. Atherosclerosis Development and Progression: The Role of Atherogenic Small, Dense LDL.
  4. Apolipoprotein E and Atherosclerosis.
  5. [A centennial retrospect and outlook in clinical dyslipidemia and atherosclerosis].
  6. Measuring LDL-cholesterol: what is the best way to do it?
  7. Combined Dyslipidemia in Children and Adolescents: a Proposed New Management Approach.
  8. [Changes in the intestinal microbiota as a risk factor for dyslipidemia, atherosclerosis and the role of probiotics in their prevention].
  9. New Recommendations and Revised Concepts in Recent Guidelines on the Management of Dyslipidemias to Prevent Cardiovascular Disease: the 2018 ACC/AHA and 2019 ESC/EAS Guidelines.
  10. Inclisiran: present and future perspectives of a new effective LDL cholesterol-lowering agent.